ARI0002h (cesnicabtagene Autoleucel), an Academic Point-of-Care B-Cell Maturation Antigen (Bcma)-Directed Chimeric Antigen Receptor (CAR) T-Cell Strategy: Activity and Safety after Fractionated Initial Therapy and Booster Dose in 60 Patients with Relapsed/Refractory Multiple Myeloma
JOURNAL OF CLINICAL ONCOLOGY（2024）
Key words
CAR T Cells
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined